Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Operating Expenses | 5,397 | 9,239 | 6,326 | 6,040 | 9,131 |
| Operating Income | -5,397 | -9,239 | -6,326 | -6,040 | -9,131 |
| Interest Expense | 10 | 7 | 14 | 18 | 15 |
| Other Income | 202 | -18 | 50 | -506 | -428 |
| Pre-tax Income | -5,205 | -9,264 | -6,290 | -6,564 | -9,574 |
| Net Income Continuous | -5,205 | -9,264 | -6,290 | -6,563 | -9,574 |
| Net Income Discontinuous | N/A | N/A | N/A | 0 | 1,536 |
| Net Income | $-5,205 | $-9,264 | $-6,290 | $-6,563 | $-8,038 |
| EPS Basic Total Ops | -0.09 | -0.21 | -0.15 | -0.20 | -0.30 |
| EPS Basic Continuous Ops | -0.09 | -0.21 | -0.15 | -0.20 | -0.35 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.00 | 0.05 |
| EPS Diluted Total Ops | -0.09 | -0.21 | -0.15 | -0.20 | -0.30 |
| EPS Diluted Continuous Ops | -0.09 | -0.21 | -0.15 | -0.20 | -0.35 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.00 | 0.05 |
| EBITDA(a) | $-5,185 | $-9,243 | $-6,263 | $-6,534 | $-9,360 |